PWG
ABBV icon

Portside Wealth Group’s AbbVie ABBV Stock Holding History

Portside Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.46M Buy
17,712
+190
+1% +$40.9K 0.52% 43
2026
Q1 		$3.81M Sell
17,522
-260
-1% -$57.7K 0.52% 43
2025
Q4 		$4.06M Sell
17,782
-270
-1% -$61.5K 0.55% 40
2025
Q3 		$4.18M Buy
18,052
+46
+0.3% +$9.37K 0.58% 37
2025
Q2 		$3.34M Sell
18,006
-113
-0.6% -$21K 0.5% 52
2025
Q1 		$3.8M Buy
18,119
+2,973
+20% +$578K 0.62% 42
2024
Q4 		$2.69M Buy
15,146
+289
+2% +$53.1K 0.45% 56
2024
Q3 		$2.93M Buy
14,857
+81
+0.5% +$15.1K 0.5% 54
2024
Q2 		$2.53M Sell
14,776
-497
-3% -$82.3K 0.48% 54
2024
Q1 		$2.78M Sell
15,273
-1,539
-9% -$265K 0.51% 52
2023
Q4 		$2.61M Sell
16,812
-576
-3% -$84K 0.49% 57
2023
Q3 		$2.59M Buy
17,388
+584
+3% +$85.7K 0.49% 53
2023
Q2 		$2.26M Buy
+16,804
New +$2.46M 0.42% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Portside Wealth Group's ABBV Position: Q2 2026 in Review

Portside Wealth Group increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $40.9K and bringing the position to 17,712 shares worth $4.46M. The position accounts for 0.52% of the portfolio, ranked #43.

Portside Wealth Group first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Portside Wealth Group held 17,712 shares of AbbVie worth $4.46M as of Q2 2026.
  • Portside Wealth Group bought 190 AbbVie shares in Q2 2026, an estimated $40.9K.
  • AbbVie made up 0.52% of Portside Wealth Group's portfolio in Q2 2026, its #43 holding.
  • Portside Wealth Group first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.